AstraZeneca Pharma India lost 4.17% to Rs 874.10 on BSE at 1027 hrs after the company reported a net loss of Rs 27.96 crore in Q2 September 2014, higher than net loss of Rs 1.23 crore in Q2 September 2013.
AstraZeneca Pharma India's net sales declined 0.9% to Rs 114.55 crore in Q2 September 2014 over Q2 September 2013.
The Q2 result was announced after market hours on Monday, 3 November 2014.
On BSE, so far 2,321 shares were traded in the counter as against average daily volume of 2,907 shares in the past one quarter.
The stock hit a high of Rs 902.60 and a low of Rs 868 so far during the day. The stock had hit a 52-week low of Rs 725.85 on 4 February 2014. The stock had hit a 52-week high of Rs 1,285 on 4 March 2014.
